Studies

CellWell record HH-340977

2026 ACC/AHA Guideline for the Management of Dyslipidemia

American College of Cardiology and American Heart Association

ACC ยท 2026

In plain language

The 2026 update describes risk-specific lipid goals and expanded use of markers such as apoB and lipoprotein(a) in selected patients.

Evidence
Established

Read it on Source

Powered by CellWell

Cite this record: https://thecellwell.org/studies/HH-340977

Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.

This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.